Wenzhou Capital logo

Wenzhou Capital

Asia, Shanghai, China, Xuhui

Description

Wenzhou Capital is a mixed-ownership professional investment organization specializing in biopharmaceutical investing.

Investor Profile

Wenzhou Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Artificial Intelligence (AI), Health Care, Health Diagnostics.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Health Care
  • Health Diagnostics
  • Machine Learning
  • Medical
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wenzhou Capital frequently co-invest with?

SAV (Scale Asia Ventures)
North America, California, United States, Palo Alto
Co-Investments: 1
Fusion Fund
North America, California, United States, Palo Alto
Co-Investments: 1
Co-Investments: 1
Samsung Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Ignite Innovation Fund
Europe, England, United Kingdom, London
Co-Investments: 1
BlueRun Ventures
North America, California, United States, San Mateo
Co-Investments: 1

What are some of recent deals done by Wenzhou Capital?

Subtle Medical

Menlo Park, California, United States

Subtle Medical is a healthcare technology company that offers AI-powered medical imaging.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningMedicalSoftware
Series BMay 13, 2024
Amount Raised: $10,000,000